secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2024-01-23T23:59:59+00:00
Accession:  0001493152-24-003441
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus amends bylaws to adopt universal proxy rules and exclusive federal forum
--------------------------------------------------------------------------------

- Board adopted amended bylaws effective Jan 22, 2024, addressing universal proxy rules (Rule 14a-19 compliance).
- Enhanced disclosure requirements for stockholder director nominations and business proposals.
- Prohibits stockholder from submitting more director nominees than seats for election.
- Requires proxy cards other than white for stockholders soliciting proxies.
- Establishes federal district courts as exclusive forum for Securities Act claims.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315224003441/0001493152-24-003441-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315224003441/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-003441

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer